Our Process

1. We determine whether GeneKey is right for you. When you first contact us, we will speak with you on the phone or in person to learn more about your case and discuss whether our genomic analysis can be helpful for your situation, or whether another option might be more appropriate. 
2. We get your oncologist's approval. As soon as you are ready to move forward, we will have a conversation with your oncologist to ensure that he or she is open to our approach, and we will confirm how we will work together. 
3. We have your tumor specimen tested. We will arrange for samples from your biopsy (tissue sample) to be sent to CLIA-approved laboratories that run GeneKey-specified tests. The biopsy samples are usually available from previously collected tumor samples or biopsies. The laboratories will provide data back for our analysis.
4. We analyze the test results. Our experts will perform in-depth analysis of the data from your cancer tissue, in order to suggest therapy options that could address the mechanisms responsible for sustaining your illness.
5. We share our findings with you and your doctor. We will present the results, together with the full scientific rationale with relevant literature citations, to you and your doctor. Our goal is to provide information to help you and your doctor optimize your treatment action plan.

Tissue Requirements

Our tissue requirements are minimal and we are flexible with regard to preservation method. Usually we can get the tissue samples we need from previous biopsies, even if the biopsy was not done with a genomic analysis in mind. If your cancer has metastasized, we may recommend using a sample from the site of the metastasis to ensure that our analysis targets the most aggressive of your cancer cells. A GeneKey representative can tell you more about what is appropriate for your specific case.

Contact us for more details.